CVS Watch Implications Revised To Negative From Developing After Change In Caremark Merger - S&P Global Ratings’ Credit Research

CVS Watch Implications Revised To Negative From Developing After Change In Caremark Merger

CVS Watch Implications Revised To Negative From Developing After Change In Caremark Merger - S&P Global Ratings’ Credit Research
CVS Watch Implications Revised To Negative From Developing After Change In Caremark Merger
Published Mar 08, 2007
504 words — Published Mar 08, 2007
Price US$ 150.00  |  Buy this Report Now

About This Report

  
Abstract:

NEW YORK (Standard&Poor's) March 8, 2007--Standard&Poor's Ratings Services said today that it revised the CreditWatch implications on CVS Corp.'s long-term ratings, including the 'BBB+' corporate credit rating, to negative from developing. The ratings were initially placed on CreditWatch on Nov. 2, 2006, when Woonsocket, R.I.-based CVS announced a definitive agreement to merge with Caremark Rx Inc. (BBB/Stable/--). The 'A-2' short-term and CP ratings on CVS are not on CreditWatch. The revision of the CreditWatch listing follows CVS' and Caremark's fourth proposal for the structure of their proposed merger. Under the prior deal structure, Standard&Poor's would most likely have affirmed the ratings. "We continue to believe that a successful merger between CVS and Caremark would

  
Brief Excerpt:

RESEARCH CVS Watch Implications Revised To Negative From Developing After Change In Caremark Merger Publication date: 08-Mar-2007 NEW YORK (Standard & Poor's) March 8, 2007--Standard & Poor's Ratings Services said today that it revised...

  
Report Type:

Ratings Action

Ticker
CVS
Issuer
CVS Health Corp.
GICS
Health Care Services (35102015)
Sector
Global Issuers , Structured Finance
Country
United States
Region
United States
Format:
PDF Adobe Acrobat
Buy Now

More from S&P Global Ratings’ Credit Research

S&P Global Ratings’ Credit Research—S&P Global Ratings’ credit research provides analysis on issuers and debt obligations of corporations, states and municipalities, financial institutions, insurance companies and sovereign governments. S&P Global Ratings also offers insight into the credit risk of structured finance deals, providing an independent view of credit risk associated with a growing array of debt-securitized instruments.

About the Author


Cite this Report

  
MLA:
S&P Global Ratings’ Credit Research. "CVS Watch Implications Revised To Negative From Developing After Change In Caremark Merger" Mar 08, 2007. Alacra Store. May 06, 2025. <http://www.alacrastore.com/s-and-p-credit-research/CVS-Watch-Implications-Revised-To-Negative-From-Developing-After-Change-In-Caremark-Merger-565863>
  
APA:
S&P Global Ratings’ Credit Research. (). CVS Watch Implications Revised To Negative From Developing After Change In Caremark Merger Mar 08, 2007. New York, NY: Alacra Store. Retrieved May 06, 2025 from <http://www.alacrastore.com/s-and-p-credit-research/CVS-Watch-Implications-Revised-To-Negative-From-Developing-After-Change-In-Caremark-Merger-565863>
  
US$ 150.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Residential Mortgage-Backed Securities from one place.